Effect of Ultrasound With Simultaneous Hyaluronate Injection on Risk of Fall in Geriatric Women With Knee Osteoarthritis

Status: Recruiting
Location: See location...
Intervention Type: Drug, Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

For many years' physiotherapists have been using ultrasound in treatment of knee osteoarthritis especially in geriatrics (people aged above 65 years) for its known therapeutic effect in relieving pain and improving knee function. Hyaluronan is used to treat osteoarthritis of the knee. Such treatments, called viscosupplementation, are administered as a course of injections into the knee joint, and are believed to supplement the viscosity of the joint fluid, thereby lubricating the joint, cushioning the joint, and producing an analgesic effect. Studies reveals the risk for falls increases with additional symptomatic OA lower limb joints and confirms in addition to gender factor; including female sex.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 65
Maximum Age: 75
Healthy Volunteers: f
View:

• Patients' ages above 65 years.

• Patients diagnosed as chronic osteoarthritis of more than 5 years.

• The OA diagnosed as grade (III to V)

• Patients failed with conventional treatment.

• All patients followed up with the same orthopedic surgeon, and they took the same type of HA intra-articular injection (HA of High MW 3000 kDa).

• All patients were medically stable and do not suffer from any other diseases which may affect the trial results.

• All patients were not treated with analgesics or any medication which may cause misleading results.

• None of the patients received intra-articular hyaluronic acid injection for 1 year or intra-articular corticosteroid injection within the last 3 months.

• All patients didn't take or oral glucosamine or chondroitin supplements or stopped these drugs 2-3 months before participating in this study.

• Every patient signed a consent form.

Locations
Other Locations
Egypt
Faculty of Physical Therapy, Badr University
RECRUITING
Cairo
Contact Information
Primary
Hend R Sakr, PhD
hend.reda@buc.edu.eg
+201010151300
Time Frame
Start Date: 2023-11-11
Estimated Completion Date: 2024-03-30
Participants
Target number of participants: 40
Treatments
Experimental: Injection group
Group (1) the study group, they will receive HA intra-articular injection in addition to 12 sessions of therapeutic ultrasound.
Other: Ultrasound group
Group (2) served as the control group, will receive only HA intra-articular knee injection.
Related Therapeutic Areas
Sponsors
Leads: Badr University

This content was sourced from clinicaltrials.gov